Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Sildenafil (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Adverse reactions
- 24 Sep 2018 According to a Food and Drug Administration media release, USFDA awarded the trial with research grant.
- 03 Jan 2018 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Dec 2017.